To investigate the molecular effects of the double treatment, RNA-seq was performed on FACS-sorted hCD45+ CML cells isolated from the bone marrow of PDX mice bearing CD34+ PTPN11-mutated CML cells and treated as described above. The gene discussed is PTPN11; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.